2-methoxyestradiol

chemical compound

Uses your system voice; voice and rate in settings.

≈ 3 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

  • English2-methoxyestradiol
  • sh2-Metoksiestradiol
  • Српски2-Metoksiestradiol
  • 日本語2-メトキシエストラジオール
  • 中文2-甲氧基雌二醇

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

2-Methoxyestradiol (2-ME2, 2-MeO-E2) is a natural metabolite of estradiol and 2-hydroxyestradiol (2-OHE2). It is specifically the 2-methyl ether of 2-hydroxyestradiol. 2-Methoxyestradiol prevents the formation of new blood vessels that tumors need in order to grow (angiogenesis), hence it is an angiogenesis inhibitor.

It also acts as a vasodilator and induces apoptosis in some cancer cell lines. 2-Methoxyestradiol is derived from estradiol, although it interacts poorly with the estrogen receptors (2,000-fold lower activational potency relative to estradiol).

However, it retains activity as a high-affinity agonist of the G protein-coupled estrogen receptor (GPER) (10 nM, relative to 3–6 nM for estradiol). It can also be used to treat alveolar echinococcosis when combined with albendazole.

Clinical development

2-Methoxyestradiol was being developed as an experimental drug candidate with the tentative brand name Panzem. It has undergone Phase 1 clinical trials against breast cancer. A phase II trial of 18 advanced ovarian cancer patients reported encouraging results in October 2007.

Preclinical models also suggest that 2-methoxyestradiol could also be effective against inflammatory diseases such as rheumatoid arthritis. Several studies have been conducted showing 2-methoxyestradiol is a microtubule inhibitor and is inhibitory against prostate cancer in rodents. , all clinical development of 2-methoxyestradiol has been suspended or discontinued.

This is significantly due to the very poor oral bioavailability of the molecule and also due to its extensive metabolism. Analogues have been developed in an attempt to overcome these problems. An example is 2-methoxyestradiol disulfamate (STX-140), the C3 and C17β disulfamate ester of 2-methoxyestradiol.

Clinical effects

2-Methoxyestradiol was found to increase sex hormone-binding globulin (SHBG) levels in men by 2.5-fold at a dose of 400 mg/day and by 4-fold at a dose of 1,200 mg/day. Conversely, it did not seem to suppress testosterone levels. A study in 2000 indicated that 2-methoxyestradiol induces G2/M cycle arrest, apoptosis and the disruption of thyroid follicles.

This process results in the release of thyroid antigens that may play a role in high incidence of thyroid autoantibodies and autoimmune thyroid disease in women.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1366157811 under CC BY-SA 4.0; modifications have been made.

Words in each sectionClinical developmentClinical developmentClinical development: 132 words132Clinical effectsClinical effectsClinical effects: 108 words108
Words in each section. Measured from the stored article body; sections below the minimum are not plotted.

Provenance

snapshot 2-methoxyestradiol-525829-813253dc8fa6409c · hash 813253dc8fa6409c8c5d52432e85795a4aec30a11da3f229605223c1d185ebf1 · captured 2026-07-26 · ledger · version history

Cite this page as: encyclopegia.org, “2-methoxyestradiol”, snapshot 2-methoxyestradiol-525829-813253dc8fa6409c. https://encyclopegia.org/a/2-methoxyestradiol

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.